Pipeline-In-A-Product: A Retrospective On The Development Of Dupixent

 
• By Jessica Merrill, Kevin Grogan, and Edwin Elmhirst
  
A Pipeline In A Product
Scrip spoke with execs at Regeneron and Sanofi about Dupixent's path to being a pipeline-in-a-product (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip